Analysis of thromboembolic events in patients with non-small cell lung cancer treated with immune checkpoint inhibitors: A single-center real-world study

被引：0
|
作者：
Kim, Tae-Hwan
Yang, Cheongin
Choi, Yong Won
Kwon, Minsuk
Lee, Hyun Woo
Kang, Seok Yun
Ahn, Mi Sun
Choi, Jin-Hyuk
机构：
[1] Ajou Univ, Sch Med, Suwon, South Korea
[2] Ajou Univ, Suwon, Gyeonggi, South Korea
[3] Ajou Univ, Suwon, South Korea
[4] Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20580
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Herzberg, Benjamin
    Campo, Meghan J.
    Gainor, Justin F.
    ONCOLOGIST, 2017, 22 (01): : 81 - 88
  • [42] Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum Chemotherapy
    Schwartzberg, Lee
    Korytowsky, Beata
    Penrod, John R.
    Zhang, Ying
    Le, T. Kim
    Batenchuk, Cory
    Krug, Lee
    CLINICAL LUNG CANCER, 2019, 20 (04) : 287 - +
  • [43] Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study
    Liguori, Luigi
    Giorgio, Gabriele
    Polcaro, Giovanna
    Pagliara, Valentina
    Malandrino, Domenico
    Perri, Francesco
    Cascella, Marco
    Ottaiano, Alessandro
    Conti, Valeria
    Servetto, Alberto
    Bianco, Roberto
    Pepe, Stefano
    Sabbatino, Francesco
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [44] RACIAL ETHNIC DIFFERENCES IN TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER WITH IMMUNE CHECKPOINT INHIBITORS: ANALYSIS OF A LARGE REAL-WORLD DATASET
    Oswald, Laura
    Gore, L. Robert
    Buhlmann, Melanie
    Brownstein, Naomi
    Turner, Kea
    Saltos, Andreas
    Gray, Jhanelle
    Gadgeel, Shirish
    Gwede, Clement
    Vadaparampil, Susan
    Gonzalez, Brian
    Jim, Heather
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1470 - A1470
  • [45] Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings
    Yoneda, Taro
    Sone, Takashi
    Koba, Hayato
    Shibata, Kazuhiko
    Suzuki, Junya
    Tani, Mayuko
    Nishitsuji, Masaru
    Nishi, Koichi
    Kobayashi, Takafumi
    Shirasaki, Hiroki
    Araya, Tomoyuki
    Kita, Toshiyuki
    Kase, Kazumasa
    Yamamura, Kenta
    Terada, Nanao
    Nishikawa, Shingo
    Tambo, Yuichi
    Kimura, Hideharu
    Kasahara, Kazuo
    CLINICAL LUNG CANCER, 2022, 23 (06) : 467 - 476
  • [46] Association of baseline characteristics and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (CPIs): Real-world evidence.
    Crawley, Danielle
    Beckmann, Kerri
    Ravindra, Saranya
    Josephs, Debra Hannah
    Spicer, James F.
    Montes, Ana
    Karapanagiotou, Eleni
    Ghosh, Sharmistha
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [47] Sequencing of ramucirumab (ram) and immune checkpoint inhibitors (ICIs) in platinum (Pt)-treated real-world patients (pts) with advanced non-small cell lung cancer (aNSCLC)
    Clarke, Jeffrey Melson
    Molife, Cliff
    Miksad, Rebecca
    Batus, Marta
    Winfree, Katherine B.
    Gossai, Anala
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort study
    Zhang, Chenyang
    Shao, Jun
    Tang, Xiaolong
    Wu, Jiayang
    Li, Peiyi
    Li, Weimin
    Wang, Chengdi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
  • [49] Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Chai, Rong
    Yin, Yipengchen
    Cai, Xuwei
    Fu, Xiaolong
    Zhang, Qin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] Hyperprogressive Disease in Advanced Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
    Lo Russo, G.
    Signorelli, D.
    Proto, C.
    Galli, G.
    Prelaj, A.
    Ferrara, R.
    Sommariva, M.
    Moro, M.
    Cancila, V.
    Ganzinelli, M.
    Brich, S.
    Sangaletti, S.
    Pruneri, G.
    Tripodo, C.
    Colombo, M. P.
    Rivoltini, L.
    Balsari, A.
    Sozzi, G.
    Boeri, M.
    Garassino, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S245 - S245
12345